Delivery Order SPE2DR25D6028-SPE2DR26FASAG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,081.15 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $2,283.84. This non-competitive, firm fixed-price delivery order was awarded on April 30, 2025, with an ultimate completion date of May 1, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,006.46 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) on October 31, 2025, with completion expected by November 3, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procurement procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a $17,056.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count units), with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract was issued on September 15, 2025, with performance to take place at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,546.68 delivery order to AmerisourceBergen Drug Corp for Ondansetron Orally Disintegrating Tablets (8mg, 30-count package) on December 3, 2025, with completion by December 4, 2025. This non-competitive delivery order employs firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,644.86 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with an ultimate completion date of December 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,618.73 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $17,662.48 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count package) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $26,647.13. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is set for ultimate completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single task under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets in unit dose packages of 100 units. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of August 18, 2025. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASAGDelivery Order
The Defense Logistics Agency awarded a $9,849.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Ondansetron 8mg tablets (30-count units) on November 24, 2025, with completion required by December 22, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency. The company demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements for military and veteran healthcare systems, delivering a wide range of products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Ondansetron, a commonly used antiemetic medication, represents a routine transaction within the contractor's substantial federal medical supply operations that support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 11/23/25 |